Novartis says it buried studies

Share this article:

Novartis says it failed to reveal 10,000 reports of side effects. The Wall Street Journal reports that the drugmaker says it has identified at least 10,000 cases which may never have been reported and which span a variety of drugs, including Gleevec, Tasigna, Exelon and Xolair.

Novartis tells the WSJ it has passed along this information to the Japanese Ministry of Health Labor and Welfare and the FDA, among others.

Novartis has been working against a series of bad PR moments, and this latest one compounds a problem highlighted two months ago, when Novartis said it had shredded or deleted some safety reports surrounding leukemia medications Gleevec and Tasigna.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters